Patent · US Active

Reduced size self-delivering RNAi compounds

US9175289B2 · kind B2 · utility

70Cited by

164References

17Claims

0Family size

Assignee

RXi Pharmaceuticals Corporation · US

Inventors

Anastasia Khvorova · Boulder, US
William Salomon · Worcester, US
Joanne Kamens · Newton, US
Dmitry Samarsky · Berlin, DE
Tod M. Woolf · Sudbury, US
James Cardia · Franklin, US

Key dates

Filing date	May 15, 2014
Grant date	Nov 3, 2015
Priority date	—
Expiry date	May 15, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to RNAi constructs with minimal double-stranded regions, and their use in gene silencing. RNAi constructs associated with the invention include a double stranded region of 8-14 nucleotides and a variety of chemical modifications, and are highly effective in gene silencing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.